Shandong Buchang Pharmaceuticals Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shandong Buchang Pharmaceuticals Co., Ltd. - overview
Established
2001
Location
Xian, Shanxi, China
Primary Industry
Pharmaceuticals
About
Founded in 2001 and based in Xian, China, Shandong Buchang Pharmaceuticals Co. , Ltd. operates as a pharmaceutical company that focuses on the production and sales of traditional Chinese medicines. Buchang Zhao, the company's founder, graduated from Xi'an Medical University and is also a senior consultant to the Chinese Medical Association of the United States.
In August 2011, Shandong Buchang Pharmaceutical raised a series F funding for CNY 66 million from new investor Brightstone Venture Capital. In November 2016, the company was listed on the Shanghai Stock Exchange. The company is mainly engaged in the research, development, production, and sales of Chinese patent medicines. Its products include Naoxintong Capsules, Wenxin Granules and Danhong Injection, covering a variety of dosage forms such as capsules, granules, and injections.
The products are suitable for the treatment of common cardiovascular and cerebrovascular diseases such as stroke, arrhythmia, insufficient blood supply, and ischemic infarction. The company generates revenue by selling traditional Chinese medicines.
Current Investors
Blackstone Group, Carlyle Group, Hina Group
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.buchang.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.